Who Paid My Doc
Systane
Drug Ophthalmology
NDC 0065-0431-04
General payments
$679,119
Research payments
$1,536,101
Through program year 2025, $679,119 in general payments and $1,536,101 in research payments were reported against Systane (Ophthalmology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $46,813 | 133 |
| 2025 | Research | $1,065,313 | 7 |
| 2024 | General | $106,027 | 104 |
| 2024 | Research | $79,385 | 2 |
| 2023 | General | $215,502 | 114 |
| 2022 | General | $243,957 | 149 |
| 2022 | Research | $341,247 | 7 |
| 2021 | General | $66,822 | 77 |
| 2021 | Research | $50,156 | 2 |
Breakdown
The top 5 of 41 recipients; each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 18 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
577 general · 18 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.